FDA Adverse Event
Injury
Summary report: N
CHLORAPREP UNKNOWN
MDR report key: 11910749
·
Received May 31, 2021
Report
- Report Number
- 3004932373-2021-00262
- Event Type
- Injury
- Date Received
- May 31, 2021
- Date of Event
- May 12, 2021
- Report Date
- May 20, 2021
- Manufacturer
- CAREFUSION 213, LLC 0113
- Product Code
- OJU
- PMA / PMN Number
- EXEMPT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
Additional Manufacturer Narrative · 1
(B)(4) INITIAL EMDR SUBMISSION. A FOLLOW UP EMDR WILL BE SUBMITTED IF ADDITIONAL INFORMATION BECOMES AVAILABLE. (B)(4). NO ADDITIONAL INFORMATION WAS PROVIDED BY THE MHRA. PRIMEVIGILANCE DID REACH OUT TO OBTAIN MORE INFORMATION WITH NO SUCCESS. SHOULD ADDITIONAL INFORMATION BE AVAILABLE IN THE FUTURE, THE COMPLAINT WILL BE RE-OPENED AND INVESTIGATED. ALL COMPLAINTS ARE REVIEWED DURING MONTHLY QUALITY/SAFETY MEETINGS. IN ADDITION, COMPLAINTS ARE TRENDED AT MONTHLY QUALITY DATA ANALYST MEETINGS AND QUARTERLY PLANT MANAGEMENT REVIEW MEETINGS.
Description of Event or Problem · 1
IT WAS REPORTED BY THE HEALTH AUTHORITY THAT THE PATIENT EXPERIENCED APPLICATION SITE RASH. APPLICATION SITE RASH.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 803274 | CHLORAPREP UNKNOWN | 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL | OJU | CAREFUSION 213, LLC 0113 | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 5 YR | Other |